On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to FDA Guidance on ZIKV Testing Strategy. Please register for CTS FDA Guidance ZIKV Testing Strategy Webinar by clicking the link: CTS FDA Guidance ZIKV Testing Strategy Webinar
We are very excited to launch our new website! Please take a few moments to click around and explore...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...